Orjoint-GM Tablet is a combination pharmaceutical formulation designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint conditions. Each tablet contains Diacerein 50 mg, Glucosamine Sulfate Potassium Chloride 750 mg, Methyl Sulfonyl Methane (MSM) 200 mg, and Methylcobalamin 750 mcg, working synergistically to provide symptomatic relief and enhance joint function. Diacerein acts as an anti-inflammatory agent by inhibiting interleukin-1 beta, thereby reducing cartilage degradation and pain. Glucosamine Sulfate Potassium Chloride serves as a vital substrate for the synthesis of glycosaminoglycans, promoting cartilage repair and maintenance. MSM contributes anti-inflammatory and antioxidant properties, potentially reducing joint stiffness and improving mobility. Methylcobalamin, an active form of vitamin B12, supports nerve health and may alleviate neuropathic pain often associated with chronic joint disorders. Orjoint-GM is indicated for patients experiencing joint pain, stiffness, and reduced mobility due to osteoarthritis or other degenerative joint diseases. It should be used under medical supervision, with consideration of patient-specific factors including comorbidities and concurrent medications. Regular monitoring is advised to assess therapeutic efficacy and detect any adverse effects. This combination offers a comprehensive approach to joint care by targeting inflammation, cartilage health, and nerve function.